These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1663562)

  • 1. Clinical pharmacokinetics of parenterally administered danofloxacin in cattle.
    Giles CJ; Magonigle RA; Grimshaw WT; Tanner AC; Risk JE; Lynch MJ; Rice JR
    J Vet Pharmacol Ther; 1991 Dec; 14(4):400-10. PubMed ID: 1663562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
    Aliabadi FS; Lees P
    J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration.
    Aliabadi FS; Lees P
    Am J Vet Res; 2001 Dec; 62(12):1979-89. PubMed ID: 11763192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung tissue concentrations and plasma pharmacokinetics of danofloxacin in calves with acute pneumonia.
    Apley MD; Upson DW
    Am J Vet Res; 1993 Jun; 54(6):937-43. PubMed ID: 8391766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf.
    Shojaee Aliabadi F; Lees P
    Res Vet Sci; 2003 Jun; 74(3):247-59. PubMed ID: 12726744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics of danofloxacin and enrofloxacin in calves challenged with Mannheimia haemolytica.
    TerHune TN; Skogerboe TL; Shostrom VK; Weigel DJ
    Am J Vet Res; 2005 Feb; 66(2):342-9. PubMed ID: 15757137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory disease.
    Sweeney MT; Papich MG; Watts JL
    J Vet Diagn Invest; 2017 Mar; 29(2):224-227. PubMed ID: 28064562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of danofloxacin in cattle and swine.
    Mann DD; Frame GM
    Am J Vet Res; 1992 Jun; 53(6):1022-6. PubMed ID: 1320812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic profiles of danofloxacin administered by two dosing regimens in calves infected with Mannheimia (Pasteurella) haemolytica.
    Sarasola P; Lees P; AliAbadi FS; McKellar QA; Donachie W; Marr KA; Sunderland SJ; Rowan TG
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3013-9. PubMed ID: 12183261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of danofloxacin in the treatment of respiratory disease in European cattle.
    Rowan TG; Sarasola P; Sunderland SJ; Giles CJ; Smith DG
    Vet Rec; 2004 May; 154(19):585-9. PubMed ID: 15160844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue disposition of danofloxacin in sheep.
    McKellar QA; Gibson IF; McCormack RZ
    Biopharm Drug Dispos; 1998 Mar; 19(2):123-9. PubMed ID: 9533113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
    Friis C
    Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the plasma pharmacokinetics and tissue concentrations of danofloxacin and enrofloxacin in broiler chickens.
    Knoll U; Glünder G; Kietzmann M
    J Vet Pharmacol Ther; 1999 Aug; 22(4):239-46. PubMed ID: 10499235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration.
    McKellar Q; Gibson I; Monteiro A; Bregante M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1988-92. PubMed ID: 10428924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition kinetics of difloxacin after intravenous, intramuscular and subcutaneous administration in calves.
    ismail M
    Vet Res Commun; 2007 May; 31(4):467-76. PubMed ID: 17216308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of experimentally induced Pasteurella haemolytica infection in dairy calves on the pharmacokinetics of flumequine.
    Mevius DJ; Breukink HJ; van Miert AS; Kessels BG; Jobse AS; Smit JA
    J Vet Pharmacol Ther; 1991 Jun; 14(2):174-84. PubMed ID: 1920605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization of bacteria to danofloxacin by temperate prophages.
    Froshauer S; Silvia AM; Chidambaram M; Sharma B; Weinstock GM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1561-3. PubMed ID: 8726041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of enrofloxacin after intravenous, intramuscular and oral administration in houbara bustard (Chlamydotis undulata macqueenii).
    Bailey TA; Sheen RS; Silvanose C; Samour JH; Garner A; Harron DW
    J Vet Pharmacol Ther; 1998 Aug; 21(4):288-97. PubMed ID: 9731951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.